The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 6.7% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 33% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 96%. Our forward projection puts the odds of a 10% gain over the next month near 28%.
REX American Resources Corporation
REX · the NYSE · USD · Market cap $1.4B
PASS · Titan EthicalAt the last full screen
2026-09-07
Screened 2026-09-07 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its distribution label.
REX American Resources Corporation holds its Distribution at $41.46. Consolidating, no directional conviction, held for 42 days.
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 42 days |
| Price at the screen | $41.46 |
| Valuation | 11.36 trailing · 18.26 forward price to earnings |
| Values screen | PASS |
| Beta | 0.63 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 1.31% | Below 33% | Interest-bearing debt is just 1.3% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 23.20% | Below 33% | Cash held in interest-bearing accounts and securities is 23.2% of assets, under the one-third limit. | Pass |
| Receivables | 0.00% | Below 49% | Money owed to the company is 0.0% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.00% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-07 screen. The gold marker is the market price at the same screen. The price runs 50.0% above the base estimate.
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-07 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsCorn prices and fuel blends offer no margin
Picture a Midwest ethanol plant turning corn into fuel additive. One good harvest or a policy tweak on blending mandates can swing results sharply, yet REX American Resources trades at nearly double our assessed fair value with a forward multiple of 20.8 times earnings.
The business clears an ethical screen and posts a moderate moat, 14 percent profit margins and 16 percent ROE. Still, 4 percent revenue growth does not justify the gap to fair value, and in a cyclical sector a seemingly reasonable multiple at peak conditions often signals the start of compression rather than a bargain.
Commodity volatility, policy shifts and thin demand visibility keep downside risk material even for a clean operator. Peak earnings rarely last, and paying a premium for them rarely ends well.
Analysis, not advice.
| Forward P/E | 18.3xfairly priced for its growth rate |
| Trailing P/E | 11.4xreasonably valued |
| EPS, trailing | 3.65 |
| EPS, forward | 2.27 |
| Revenue growth | +17.9%steady growth |
| Profit margin | 17.6%healthy profit margins |
| Return on equity | 19.6%a solid return on shareholder capital |
| FCF yield | 3.49% |
| Debt to equity | 2.31heavy leverage: higher risk if revenue softens |
| Current ratio | 6.88comfortably covers its short-term bills |
| Beta | 0.63steadier than the market |
| Short interest, float | 0.03% |
| 52-week range | 30.02 - 53.36 |
| Moat | MODERATE |
| Market cap | $1.4B |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeREX trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 1.1% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 33% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 96%. Our forward projection puts the odds of a 10% gain over the next month near 28%.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 33% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 96%. Our forward projection puts the odds of a 10% gain over the next month near 28%.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 26 Feb2025 | Daniel Webster | Republican | sell | 15K–50K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $49.40 | -11.2% | · | $888 | -11.2% |
| 2 months | $44.21 | -0.8% | · | $992 | -0.8% |
| 3 months | $39.55 | +10.9% | · | $1,109 | +10.9% |
| 6 months | $33.31 | +31.7% | · | $1,317 | +31.7% |
| 1 year | $22.41 | +95.8% | · | $1,958 | +95.8% |
| 2 years | $23.53 | +86.4% | · | $1,864 | +86.4% |
| 3 years | $17.01 | +157.8% | · | $2,578 | +157.8% |
| 5 years | $16.09 | +172.6% | · | $2,726 | +172.6% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever REX does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.